Skip to content

    Niva Bupa Health

    NIVABUPAGood
    Financial Services·3 Nov 2025
    Management Summary

    Niva Bupa Health reported a strong H1 FY26 with significant growth in profitability and premiums, led by its retail segment. The management was particularly bullish on the recent GST reduction to 0%, which has already resulted in a dramatic uptick in demand in October. The company has made a strategic decision to pass on the entire GST-related commission impact to distributors, confident that increased volumes and higher ticket sizes will more than compensate, positioning it for accelerated growth.

    Highlights

    8
    • H1 FY26 GWP grew 23% YoY on a like-to-like basis to ₹3,983 crores.

    • H1 FY26 IFRS Profit After Tax (PAT) more than doubled to ₹132 crores from ₹60 crores YoY.

    • H1 FY26 Combined Ratio (IFRS) improved by 105 bps to 103.1% from 104.2% YoY, driven by expense ratio reduction.

    • Retail segment growth was strong at 28% YoY for H1 FY26, with a stable retail loss ratio of 68.1%.

    • The reduction of GST on health insurance to 0% spurred a >50% YoY growth in retail business for October 2025.

    • The company has fully passed on the commission impact from the GST change to distributors, betting on higher volumes.

    • Solvency ratio remains healthy at 2.85x as of September 30, 2025.

    • Expense of Management (EOM) ratio improved by 370 bps YoY to 36.3% for H1 FY26.

    Key financials

    Metrics

    6

    Periods

    3

    Headline

    2
    • AUM
      ₹8,482 Cr
    • Solvency Ratio
      2.85 x

    H1

    3
    • GWP
      ₹3,983 Cr
      YoY+23%
    • IFRS PAT
      ₹132 Cr
      YoY+120%
    • EOM Ratio
      36.3%

    IFRS, H1

    1
    • Combined Ratio
      103.1%

    Segment breakdown

    Retail Health
    28.0% Growth (H1, like-to-like)68.1% Loss Ratio (IFRS, H1)
    Group Health
    13% Growth (H1, without 1/N)60.9% Loss Ratio (IFRS, H1)
    List

    Guidance & targets

    3
    CategoryTargetPriority
    Profitability
    Long-term ROE
    mid to high teens
    High
    Expense
    EOM Ratio
    Within regulatory limit
    High
    Pricing
    Price Revision
    No revision
    High

    Risks & concerns

    4
    RiskSeverity

    Group Loss Ratio Increase

    The group loss ratio increased from 56% to 60.9% YoY in H1. Management attributed this to a change in business mix towards large corporates, which was offset by lower expense ratios.Analyst acknowledged

    medium

    EOM Ratio Above Regulatory Limit

    Management stated the H1 EOM ratio was 50 bps above the allowable limit. They expressed confidence in bringing it within the full-year limit as per their glide path.Management acknowledged

    medium

    GST Impact on Non-Commission Overheads

    Analysts questioned the impact of non-availability of input tax credit on overheads. Management believes this will be more than compensated by volume growth and lower GST on pharmacy claims.Analyst acknowledged

    low

    Areas of Evasion(1)

    • Declined to quantify the percentage of the portfolio that follows cohort-based/experience-based pricing, suggesting to take it offline.

    Q&A highlights

    3

    “Yes. Yes, we have passed on entirely to the distributor. And as I explained, the distributor has also understood this that this is ultimately benefiting him because his income is going up. His income is not going down because the volume is going up, ticket size is also going up.”

    This confirms a critical strategic decision to prioritize volume growth over protecting margins from the ITC impact, signaling confidence in the demand elasticity of the product.

    asked by Prayesh Jain

    2 min read5 chapters

    Detailed Narrative

    01

    GST Reduction Sparks Unprecedented Demand

    The central theme of the call was the reduction of GST on health insurance from 18% to 0%, which management termed an "incredible win for the industry." Niva Bupa has fully passed on this benefit to customers and the associated commission impact to distributors. This strategy yielded immediate, dramatic results, with retail business growing over 50% in October, a historically slow month. Furthermore, the ticket size for new retail business in October jumped by 15% compared to H1, indicating customers are using the savings to buy more adequate cover.

    02

    H1 Financial Performance: Strong Growth and Improved Profitability

    Niva Bupa reported robust financial performance for H1 FY26. Gross Written Premium (GWP) grew 23% YoY on a like-to-like basis to ₹3,983 crores. Profit After Tax under IFRS more than doubled, rising to ₹132 crores from ₹60 crores in the same period last year. The IFRS Combined Ratio improved by 105 basis points to 103.1%, driven by a 2.3% reduction in the expense ratio, which more than offset a 1.2% increase in the overall loss ratio.

    03

    Segment Dynamics: Retail Powers Growth, Group Remains Selective

    The retail segment was the primary growth engine, expanding 28% YoY in H1. The retail loss ratio remained stable at 68.1% on an IFRS basis. In contrast, the group business grew by a more moderate 13%, with management citing a high base from the previous year and a selective underwriting approach. The group loss ratio increased from 56% in H1 FY25 to 60.9% in H1 FY26, attributed to the mix of large corporate clients onboarded.

    04

    Operational Efficiency and Strategic Investments

    The company demonstrated improved operational leverage, with the Expense of Management (EOM) ratio falling to 36.3% from 40% YoY. While this was 50 bps above the H1 allowable limit, management is confident of meeting the full-year regulatory target. The company is also investing heavily for future growth, having increased its distribution headcount by over 1,000, established an AI lab, and launched a new microservices-based core system to enhance product agility and customer service.

    05

    Claims Management and Network Strategy

    Customer metrics remained strong, with a claims settlement ratio of 95.2% in Q2 and an improved weighted average NPS of 57 across 35 touchpoints. The company's Preferred Provider Network (PPN) strategy is gaining traction, with about 17% of claims in cities with PPN presence being routed through these hospitals. Management noted that incidence rates and average claim sizes have remained stable, contributing to a predictable claims environment.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.